Skip to main content
SpringerLink
Log in

Multidimensional perspective of obesity; prevention to treatment

  • Review article
  • Published:
Journal of Diabetes & Metabolic Disorders Aims and scope Submit manuscript

Abstract

Objective

An increasing prevalence of overweight and obesity across the world can lead to serious health complications. The present narrative review highlighted the results of research on obesity management affiliated to the Endocrinology and Metabolism Research Institute (EMRI), Tehran University of Medical Sciences.

Methods

All documents from the EMRI focused on obesity topics were searched using PubMed and Scopus databases up to December 2019.

Results

EMRI research projects conducted in obesity field cover several topics including childhood obesity, epidemiology of obesity, roles of genetic factors and gut microbiota in excess weight, as well as weight management by medicinal herbs and nutritional interventions. The increasing prevalence of excess-weight in children and adults indicates that conventional weight management strategies alone are not successful in obesity control and complementary therapies including herbal medicine could be helpful. Moreover, clarifying the role of the human genome and microbiome in different responses of individuals to dietary recommendations could be effective in achieving personalized nutrition.

Conclusion

Further population-based studies focusing on national and international collaborations are needed to progress more practical strategies to face with obesity challenge in different age ranges.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Data availability

Not applicable.

References

  1. Hossain P, Kawar B, El Nahas M. Obesity and diabetes in the developing world-a growing challenge. N Engl J Med. 2007;356(3):213–5.

  2. Jafari-Adli S, Jouyandeh Z, Qorbani M, Soroush A, Larijani B, Hasani-Ranjbar S. Prevalence of obesity and overweight in adults and children in Iran; a systematic review. J Diabetes Metab Disord. 2014;13(1):121.

    Article  Google Scholar 

  3. World Health Organization. Obesity and overweight: World Health Organization. 2006. https://www.who.int/news-room/fact-sheets/detail/obesity-andoverweight

  4. Ahadi Z, Shafiee G, Qorbani M, Sajedinejad S, Kelishadi R, Arzaghi SM, et al. An overview on the successes, challenges and future perspective of a national school-based surveillance program: the CASPIAN study. J Diabetes Metab Disord. 2014;13(1):120.

    Article  Google Scholar 

  5. Angoorani P, Heshmat R, Ejtahed HS, Motlagh ME, Ziaodini H, Taheri M, et al. The association of parental obesity with physical activity and sedentary behaviors of their children: the CASPIAN-V study. J Pediatr (Versão em Português). 2018;94(4):410–8.

    Article  Google Scholar 

  6. Ejtahed HS, Heshmat R, Motlagh ME, Hasani-Ranjbar S, Ziaodini H, Taheri M, et al. Association of parental obesity with cardiometabolic risk factors in their children: The CASPIAN-V study. J Clin Res Pediatr Endocrinol. 2018;13(4):e0193978.

    Google Scholar 

  7. Angoorani P, Heshmat R, Ejtahed H-S, Motlagh ME, Ziaodini H, Taheri M, et al. Validity of triglyceride–glucose index as an indicator for metabolic syndrome in children and adolescents: the CASPIAN-V study. Eating and weight disorders-studies on anorexia. Bulimia Obes. 2018;23(6):877–83.

    Google Scholar 

  8. Angoorani P, Khademian M, Ejtahed H-S, Heshmat R, Motlagh ME, Vafaeenia M, et al. Are non-high–density lipoprotein fractions associated with pediatric metabolic syndrome? The CASPIAN-V study. Lipids Health Dis. 2018;17(1):257.

    Article  CAS  Google Scholar 

  9. Ejtahed HS, Kelishadi R, Qorbani M, Motlagh ME, Hasani‐Ranjbar S, Angoorani P, Beshtar S, Ziaodini H, Taheri M, Heshmat R. Utility of waist circumference‐to‐height ratio as a screening tool for generalized and central obesity among Iranian children and adolescents: The CASPIAN‐V study. Pediat Diab. 2019;20(5):530–7.

  10. Heshmat R, Heidari M, Ejtahed H-S, Motlagh ME, Mahdavi-Gorab A, Ziaodini H, et al. Validity of a continuous metabolic syndrome score as an index for modeling metabolic syndrome in children and adolescents: the CASPIAN-V study. Diabetol Metab Syndr. 2017;9(1):89.

    Article  Google Scholar 

  11. Ejtahed H-S, Qorbani M, Motlagh ME, Angoorani P, Hasani-Ranjbar S, Ziaodini H, et al. Association of anthropometric indices with continuous metabolic syndrome in children and adolescents: the CASPIAN-V study. Eating and weight disorders-studies on anorexia. Bulimia Obes. 2018;23(5):597–604.

    Google Scholar 

  12. Payab M, Kelishadi R, Qorbani M, Motlagh ME, Hasani-Ranjbar S, Ejtahed HS, Ardalan G, Arefirad T, Asayesh H, Heshmat R. Association of healthy foods intake with anthropometric measures and blood pressure in a national sample of Iranian children and adolescents: the CASPIAN-IV Study. Minerva Pediat. 2016;71(5):420–30.

  13. Payab M, Kelishadi R, Qorbani M, Motlagh ME, Ranjbar SH, Ardalan G, et al. Association of junk food consumption with high blood pressure and obesity in Iranian children and adolescents: the CASPIAN-IV Study. J Pediatr. 2015;91(2):196–205.

    Article  Google Scholar 

  14. Zahedi H, Kelishadi R, Heshmat R, Hasani SR, Esmaeil MM, Ardalan G, et al. Association of adolescents’ weight status with life satisfaction: role of self, peers, family and school perception; the CASPIAN-IV Study. Minerva Pediatr. 2019;71(3):235–41.

    Article  Google Scholar 

  15. Hasani-Ranjbar S, Shirzad N, Mashayekh Bakhshi F. A 3-year-old boy with severe obesity and pseudoacromegaly; short course treatment with Orlistat. Iran J Diabetes Lipid Disord. 2010;9:1–5.

    CAS  Google Scholar 

  16. Payab M, Hasani-Ranjbar S, Merati Y, Esteghamati A, Qorbani M, Hematabadi M, et al. The prevalence of metabolic syndrome and different obesity phenotype in Iranian male military personnel. Am J Men’s Health. 2017;11(2):404–13.

    Article  Google Scholar 

  17. Ejtahed HS, Soroush MR, Hasani-Ranjbar S, Angoorani P, Mousavi B, Masumi M, et al. Prevalence of metabolic syndrome and health-related quality of life in war-related bilateral lower limb amputees. J Diabetes Metab Disord. 2017;16:17.

    Article  Google Scholar 

  18. Gholami M, Sharifi F, Shahriari S, Khoshnevisan K, Larijani B, Amoli MM. Association of interleukin-6 polymorphisms with obesity: A systematic review and meta-analysis. Cytokine. 2019;123:154769.

    Article  CAS  Google Scholar 

  19. Hasani-Ranjbar S, Amoli MM, Tabatabaei-Malazy O, Rumi Y, Tavakkoly-Bazzaz J, Samimi H, et al. Effect of adiponectin gene polymorphisms on waist circumference in patients with diabetes. J Diabetes Metab Disord. 2012;11(1):14.

    Article  Google Scholar 

  20. Payab M, Amoli MM, Qorbani M, Hasani-Ranjbar S. Adiponectin gene variants and abdominal obesity in an Iranian population. Eati Weight Disord. 2017;22(1):85–90.

    Article  Google Scholar 

  21. Tabatabaei-Malazy O, Hasani-Ranjbar S, Amoli MM, Heshmat R, Sajadi M, Derakhshan R, et al. Gender-specific differences in the association of adiponectin gene polymorphisms with body mass index. Rev Diabet Stud. 2010;7(3):241.

    PubMed  PubMed Central  Google Scholar 

  22. Talaschian M, Amoli MM, Enayati S, Payab M, Hasani-Ranjbar S. Association between Trp48Arg polymorphism of the CD11c gene and risk for obesity among Iranian population. J Diabetes Metab Disord. 2018;17(2):197–201.

    Article  CAS  Google Scholar 

  23. Payab M, Hasani-Ranjbar S, Aletaha A, Ghasemi N, Qorbani M, Atlasi R, et al. Efficacy, safety, and mechanisms of herbal medicines used in the treatment of obesity: A protocol for systematic review. Medicine. 2018;97(1):e8825.

    Article  Google Scholar 

  24. Hasani-Ranjbar S, Jouyandeh Z, Abdollahi M. A systematic review of anti-obesity medicinal plants-an update. J Diabetes Metab Disord. 2013;12(1):28.

    Article  Google Scholar 

  25. Hasani-Ranjbar S, Nayebi N, Larijani B, Abdollahi M. A systematic review of the efficacy and safety of herbal medicines used in the treatment of obesity. World J Gastroenterol. 2009;15(25):3073.

    Article  CAS  Google Scholar 

  26. Namazi N, Larijani B, Ayati MH, Abdollahi M. The effects of Nigella sativa L. on obesity: A systematic review and meta-analysis. J Ethnopharmacol. 2018;219:173–81.

    Article  CAS  Google Scholar 

  27. Kamali SH, Khalaj AR, Hasani-Ranjbar S, Esfehani MM, Kamalinejad M, Soheil O, et al. Efficacy of ‘Itrifal Saghir’, a combination of three medicinal plants in the treatment of obesity; A randomized controlled trial. Daru. 2012;20(1):33.

    Article  Google Scholar 

  28. Mousavi S, Milajerdi A, Sheikhi A, Kord-Varkaneh H, Feinle‐Bisset C, Larijani B, et al. Resveratrol supplementation significantly influences obesity measures: a systematic review and dose–response meta‐analysis of randomized controlled trials. Obes Rev. 2019;20(3):487–98.

    Article  CAS  Google Scholar 

  29. Mousavi SM, Milajerdi A, Varkaneh HK, Gorjipour MM, Esmaillzadeh A. The effects of curcumin supplementation on body weight, body mass index and waist circumference: a systematic review and dose-response meta-analysis of randomized controlled trials. Crit Rev Food Sci Nutri. 2020;60(1):171–80.

  30. Tabatabaei-Malazy O, Shadman Z, Ejtahed H-S, Atlasi R, Abdollahi M, Larijani B. Quality of reporting of randomized controlled trials of herbal medicines conducted in metabolic disorders in Middle East countries: A systematic review. Complement Ther Med. 2018;38:61–6.

    Article  Google Scholar 

  31. Mansouri M, Nayebi N, Hasani-Ranjbar S, Taheri E, Larijani B. The effect of 12 weeks Anethum graveolens (dill) on metabolic markers in patients with metabolic syndrome; a randomized double blind controlled trial. DARU J Pharm Sci. 2012;20(1):47.

    Article  Google Scholar 

  32. Ejtahed HS, Soroush AR, Angoorani P, Larijani B, Hasani-Ranjbar S. Gut microbiota as a target in the pathogenesis of metabolic disorders: a new approach to novel therapeutic agents. Horm Metab Res. 2016;48(6):349-58.

  33. Ejtahed HS, Angoorani P, Soroush AR, Siadat SD, Shirzad N, Hasani-Ranjbar S, Larijani B. Our little friends with big roles: alterations of the gut microbiota in thyroid disorders. Endocrine Metabolic & Immune Disorders-Drug Targets. 2020;20(3):344-50.

  34. Aazami H, DehghanBanadaki H, Ejtahed HS, Fahimfar N, Razi F, Soroush AR, Hasani-Ranjbar S, Pasalar P, Badi SA, Siadat SD, Larijani B. The landscape of microbiota research in Iran; a bibliometric and network analysis. J Diab Metab Disord. 2020;1–5.

  35. Ejtahed HS, Tabatabaei-Malazy O, Soroush AR, Hasani-Ranjbar S, Siadat SD, Raes J, et al. Worldwide trends in scientific publications on association of gut microbiota with obesity. Iran J Basic Med Sci. 2019;22(1):65–71.

    PubMed  PubMed Central  Google Scholar 

  36. Ejtahed HS, Hasani-Ranjbar S. Neuromodulatory effect of microbiome on gut-brain axis; new target for obesity drugs. J Diabetes Metab Disord. 2019;18(1):263–5.

    Article  Google Scholar 

  37. Ejtahed HS, Hasani-Ranjbar S, Larijani B. Human microbiome as an approach to personalized medicine. Altern Ther Health Med. 2017;23(6):8–9.

    PubMed  Google Scholar 

  38. Ejtahed H-S, Angoorani P, Hasani-Ranjbar S, Siadat S-D, Ghasemi N, Larijani B, et al. Adaptation of human gut microbiota to bariatric surgeries in morbidly obese patients: a systematic review. Microb Pathog. 2018;116:13–21.

    Article  Google Scholar 

  39. Tabasi M, Ashrafian F, Khezerloo JK, Eshghjoo S, Behrouzi A, Javadinia SA, et al. Changes in gut microbiota and hormones after bariatric surgery: a bench-to-bedside review. Obes Surg. 2019;29(5):1663–74.

    Article  Google Scholar 

  40. Ejtahed H-S, Soroush A-R, Siadat S-D, Hoseini-Tavassol Z, Larijani B, Hasani-Ranjbar S. Targeting obesity management through gut microbiota modulation by herbal products: A systematic review. Complement Ther Med. 2019;42:184–204.

    Article  Google Scholar 

  41. Homayouni-Rad A, Soroush AR, Khalili L, Norouzi-Panahi L, Kasaie Z, Ejtahed HS. Diabetes management by probiotics: current Knowledge and Future Pespective. Int J Vitam Nutr Res. (Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition). 2016;86(3-4):215–27.

  42. Ejtahed HS, Angoorani P, Soroush AR, Atlasi R, Hasani-Ranjbar S, Mortazavian AM, et al. Probiotics supplementation for the obesity management; A systematic review of animal studies and clinical trials. J Funct Foods. 2019;52:228–42.

    Article  CAS  Google Scholar 

  43. Rad AH, Abbasalizadeh S, Vazifekhah S, Abbasalizadeh F, Hassanalilou T, Bastani P, et al. The future of diabetes management by healthy probiotic microorganisms. Curr Diabetes Rev. 2017;13(6):582–9.

    Article  Google Scholar 

  44. Ejtahed HS, Tito RY, Siadat SD, Hasani-Ranjbar S, Hoseini-Tavassol Z, Rymenans L, Verbeke K, Soroush AR, Raes J, Larijani B. Metformin induces weight loss associated with gut microbiota alteration in non-diabetic obese women: a randomized double-blind clinical trial. Eur J Endocrinol. 2019;180(3):165–76.

  45. Mansouri M, Hasani-Ranjbar S, Yaghubi H, Rahmani J, Tabrizi YM, Keshtkar A, Varmaghani M, Sharifi F, Sadeghi O. Breakfast consumption pattern and its association with overweight and obesity among university students: a population-based study. Eating Weight Disord-Stud Anorexia Bulimia Obes. 2020;25(2):379–87.

  46. Namazi N, Irandoost P, Larijani B, Azadbakht L. The effects of supplementation with conjugated linoleic acid on anthropometric indices and body composition in overweight and obese subjects: A systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2019;59(17):2720–33.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Obesity and Eating Habits Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Hanieh-Sadat Ejtahed, Shirin Hasani-Ranjbar & Ahmad-Reza Soroush

  2. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Hanieh-Sadat Ejtahed, Shirin Hasani-Ranjbar, Ahmad-Reza Soroush & Bagher Larijani

Authors
  1. Hanieh-Sadat Ejtahed
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shirin Hasani-Ranjbar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ahmad-Reza Soroush
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Bagher Larijani
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

HSE, SHR and BL designed the study and drafted the manuscript. ARS helped in data extraction and interpretation of data. All authors read and approved the final manuscript.

Corresponding authors

Correspondence to Shirin Hasani-Ranjbar or Ahmad-Reza Soroush.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Consent for publication

Not applicable.

Ethics approval and consent to participate

Not applicable.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ejtahed, HS., Hasani-Ranjbar, S., Soroush, AR. et al. Multidimensional perspective of obesity; prevention to treatment. J Diabetes Metab Disord (2021). https://doi.org/10.1007/s40200-020-00705-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s40200-020-00705-y

Keywords

Search

Navigation